2020 U.S. POC Clinical Chemistry and Immunodiagnostics Forecasts for 100 Tests: Supplier Shares and Strategies, Instrumentation Review, Emerging technologies--Physician Offices, ER, OR, ICU, Cancer Clinics, Ambulatory Care, Surgery and Birth Centers, Nursing Homes

This new 373-page report contains 61 tables, and provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for clinical chemistry procedures
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major clinical chemistry reagent and instrument suppliers.

Current and Emerging Products

- Analysis of clinical chemistry procedures performed in POC testing locations.
- Review of leading clinical chemistry analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing clinical Chemistry
   testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new clinical chemistry instruments and reagent systems
   with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and s proprietary data files.


Introduction
Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Review of Clinical Chemistry Tests
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. Calcium
11. Cholesterol
12. Cholinesterase
13. Creatinine
14. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium

15. Ferritin
16. Follate/Folic Acid
17. Fructosamine
18. Gamma-Glutamyl Transpeptidase (GGT)
19. Glucose
20. High Density Lipoprotein (HDL)
21. Iron
22. Lactate Dehydrogenase (LDH)
23. Magnesium
24. Phosphorus
25. Protein
26. Triglycerides
27. Troponin
28. Uric Acid
29. Urinalysis
30. Vitamin B12
Instrumentation: Chemistry Analyzers Manufactured by:
- Abaxis
- Abbott
- Alfa Wassermann
- Awareness Technologies
- Beckman Coulter/Danaher
- bioMeriuex
- Carolina Chemistries
- Horiba
- Inverness
- Medica
- Nova Biomedical
- Ortho-Clinical Diagnostics
- Polimedco
- Randox
- Roche
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)

Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
U.S.A.
Self-Sustained Sequence Replicase
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay

i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts
E. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
F. Surgery Centers
1. Introduction
2. Market Summary

3. Market Structure
4. Test Volume and Sales Forecasts
G. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Birth Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. Major Suppliers’ Sales and Market Shares
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations

E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
IL/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako


List Of Tables


Major Companies Developing or Marketing
Albumin Tests
Major Companies Developing or Marketing
Alkaline Phosphatase Tests
Major Companies Developing or Marketing
ALT/SGPT Tests
Major Companies Developing or Marketing
Amylase Tests
Major Companies Developing or Marketing
AST/SGOT Tests
Major Companies Developing or Marketing
Bilirubin Tests
Major Companies Developing or Marketing
Blood Gas Analyzers
Major Companies Developing or Marketing
BUN Tests
Major Companies Developing or Marketing
Calcium Tests
Major Companies Developing or Marketing
Cholesterol Tests
Major Companies Developing or Marketing
Creatinine Tests
Major Companies Developing or Marketing
Electrolyte Tests
Major Companies Developing or Marketing
Ferritin Tests

Major Companies Developing or Marketing
GGT Tests
Major Companies Developing or Marketing
Glucose Tests
Major Companies Developing or Marketing
HDL Tests
Major Companies Developing or Marketing
Iron Tests
Major Companies Developing or Marketing
LDH Tests
Major Companies Developing or Marketing
Magnesium Tests
Major Companies Developing or Marketing
Phosphorus Tests
Major Companies Developing or Marketing
Protein Tests
Major Companies Developing or Marketing
Triglycerides Tests
Major Companies Developing or Marketing
Uric Acid Tests
Major Companies Developing or Marketing
Vitamin B-12/Folate Tests

U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., Office-Based Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine and Special Chemistry Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Routine and Special Chemistry Test Volume
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine and Special Chemistry
Reagent Market Forecast By Test
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine
And Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments
Profiles, Panels and Individual Tests
U.S.A., Hospital Emergency Departments
Routine and Special Chemistry Reagent
Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites
Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Routine and Special Chemistry Reagent
Market Forecast by Test

U.S.A., Hospital ICUs/CCUs Routine
And Special Chemistry Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine
And Special Reagent Market Forecast by Test
U.S.A., Cancer Clinics Routine
And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine and Special Chemistry
Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Surgery Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes
Estimated Number of Facilities,
Beds and Occupancy Rate
U.S.A., Nursing Homes Routine
And Special Chemistry Test Volume Forecast

U.S.A., Nursing Homes Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers Routine
And Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles,
Panels and Individual Tests
U.S.A., Birth Centers Routine
And Special Chemistry Reagent Market Forecast by Test
U.S.A., Major Suppliers of Clinical Chemistry
Diagnostic Products Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Analyzers, Estimated Market Shares
U.S.A., Major Suppliers of Immunodiagnostic
Products, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay
Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay
Analyzers, Estimated Market Shares


United States Toys Market – Growth, Demand, Trends, Opportunity, Forecasts (2020 – 2027)

The United States toys market is set to surpass US$ 56 Billion by 2027.Report Scope: The Market Size of the United States Toys Market with Six Years Forecast The United

USD 900 View Report

United States Self-Monitoring Blood Glucose (SMBG) Market Analysis 2015 – 2020 and Industry Forecast 2021 – 2027

The United States market for the self-monitoring blood glucose is anticipated to cross US$ 4.6 billion by the year-end of 2027.

USD 2500 View Report

2020 U.S. Tumor Markers Sales Segment Forecasts: Supplier Shares and Strategies, Emerging Tests, Technologies and Opportunities

This new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S. cancer

USD 4500 View Report

2020 U.S. POC Infectious Disease Testing Market: Supplier Shares, Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review--Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers

This new 795-page report contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape,

USD 5500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available